Does the 2025–26 COVID Shot Still Help Adults Avoid the ER and Hospital?

A CDC-led study in JAMA Network Open found the 2025–26 COVID-19 vaccine was associated with about 50% lower odds of COVID-related ER/urgent care visits and about 55% lower odds of hospitalization in immunocompetent adults—benefits that looked similar for adults 65+.

If you’ve had COVID before and also got vaccinated, it’s reasonable to wonder: does the newest shot still help enough to matter? A CDC-led study in JAMA Network Open suggests yes—especially for the outcomes that most often land people in the ER or the hospital.

In this real-world analysis, adults who received the 2025–26 COVID-19 vaccine had about 50% lower odds of COVID-related emergency department/urgent care visits and about 55% lower odds of COVID-related hospitalization compared with adults who did not receive that season’s dose.

What the study was looking at

The study used an observational, test-negative design—an approach that compares vaccinated and unvaccinated people who seek care for a COVID-like illness, based on whether their test is positive. This design is commonly used in vaccine-effectiveness research and helps address some differences in health-seeking behavior, though it is not the same as a randomized trial.

Dates: The analysis included encounters from September 3, 2025 through December 31, 2025.

Who was included: Immunocompetent U.S. adults (people with normal immune function).

Outcomes: COVID-related ER/urgent care visits and COVID-related hospitalizations.

Key results in plain numbers

Across immunocompetent adults, the estimated association with the 2025–26 vaccine was:

  • ~50% lower odds of COVID-associated ER/urgent care visits
  • ~55% lower odds of COVID-associated hospitalization

For people 65 years and older, the study reported protection in a similar range for both ER/urgent care and hospitalization outcomes.

The study also found evidence of added benefit even in a population with substantial prior immunity from previous infection and/or vaccination.

How to interpret this (without hype)

This study answers an important, practical question: does the newest COVID vaccine still lower the risk of medically attended, serious outcomes? During the months studied, the answer appears to be yes.

But it doesn’t prove everything:

  • Not “sterilizing” immunity: The vaccine is associated with fewer ER/urgent care visits and hospitalizations, but it doesn’t guarantee you won’t get infected.
  • Interim effectiveness: Effectiveness can change over time, especially as more time passes after vaccination and as variants circulate.
  • Not focused on everyone: This estimate is for immunocompetent adults; people with weakened immune systems may need different considerations.
  • Observational limits still apply: Real-world studies rely on assumptions. The test-negative approach helps, but it’s not as definitive as a randomized trial.

Who may benefit most?

ER/urgent care visits and hospitalization are exactly the kinds of outcomes that tend to be most disruptive—and most dangerous—for older adults and people at higher risk of severe COVID-19.

CDC’s routine 2025–26 COVID-19 vaccination guidance emphasizes that vaccination decisions should be based on risk and shared clinical decision-making, particularly for people at increased risk of severe disease.

If you’re 65+ or you have health conditions or circumstances that raise your risk, the new study’s findings are especially relevant.

What readers can do next

  • Follow current CDC guidance for your age and vaccination history.
  • If you’re unsure, ask a clinician or pharmacist about timing—especially if you recently had COVID or have conditions that affect your immune system.
  • Use urgent-care safety habits: If you develop severe symptoms—like trouble breathing, severe dehydration, confusion, chest pain, or rapidly worsening symptoms—seek emergency care right away.
  • Keep expectations realistic: COVID vaccination can reduce risk of medically serious outcomes, but it’s one layer of protection alongside staying up to date and using prevention steps when transmission is high.

What remains uncertain

Even with promising interim results, some questions remain:

  • Durability: How protection changes month-to-month after vaccination.
  • Broader groups: How effectiveness looks in people with weakened immune systems and in children.
  • Variant timing: Protection can vary depending on which variants are circulating when someone becomes ill.

For many families, the bottom line is clear: even after prior infection and prior vaccination, getting the 2025–26 shot may still reduce the chance of the COVID-related illnesses that lead to ER visits and hospital stays—particularly for older adults and those at higher risk.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.